Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quick-acting Jiuxin Pill for chronic stable angina
ChiCTR1900021876Phase 4Not yet recruiting
- Sponsor
- Shuguang Hospital
- Start
- Apr 2019
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Suxiao Jiuxin Pills in angina pectoris (3 arms), sponsored by Shuguang Hospital. Primary endpoints: Effect of angina pectoris and Incidence of cardiovascular events. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
Suxiao Jiuxin Pills
03
Conditions
angina pectoris
Beyond the preview
Go deeper on ChiCTR1900021876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021876.